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Introduction
The phylloides tumor (PT) was first described by Mullaer
in 1838 as a rare breast neoplasm of fibro-epithelial origin.
Ever since then there has been a controversy regarding its
nomenclature. It was previously called cytosarcoma
phylloides but at present the WHO recommended term
‘Phylloides Tumor’ is largely used (WHO, 1981).These
tumors are large, bulky, fast growing masses that originate
from the intralobular stroma of the breast. PTs are
histologically classified as benign (BPT), borderline (BLPT),
or malignant (MPT) depending on cellular atypia, anaplasia,
and degree of mitotic activity and infiltration. Overall, PTs
account for less than 1% of all breast neoplasms (Tavassoli
and Devilee, 2003) and are only very rarely seen in
adolescent females. The average age of presentation is 40-
50 years, around 15-20 years older than fibroadenomas (FAs)
(Tavassoli and Devilee, 2003; Azzopardi, 1979; Chu et al.,
1988). Malignant PTs develop on the average 2-5 years later
than benign PTs. In Asians, however, PT occurs at a younger
age, with an average of 25-30 years (Chua et al., 1988).
PTs are a group of biphasic tumors basically analogous
to FAs, characterized by a double layered epithelial
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Abstract
The objective of this study was to determine the frequency of phylloides tumor (PT) in adolescent girls and young
women (less than and equal to 25 years of age) and to define the clinico-pathological features of PT in this unusual
clinical setting. This descriptive study was carried out at the Aga Khan University Hospital (AKUH) pathology
department. All consecutive cases of PT diagnosed during the last sixteen years in the section of histopathology from
1st January 1990 to 31st June 2005 were included. Selection of cases was restricted to patients up to 25 years of age.
A total of 42 cases of PT in up to 25 years of age were diagnosed. This comprised 11% of the total PT cases (total
n=363). The number of benign (BPT), borderline (BLPT) and malignant (MPT) was identical i.e. 14 (33.3%) each.
Clinically all cases presented with a solid, mobile, palpable mass. The mean age was 19.1 years (95% CI, 16.7-21.6),
21.9 years (95% CI, 20.7-21.9) and 19.7 years (95% CI, 17.2-22.3) in BPT, BLPT and MPT respectively. In majority
of cases the surgical procedure performed was lumpectomy (50% of BPT, 78% of BLPT and 64% of MPT).  High
grade PT (BLPT and MPT) is an uncommon mammary tumor in adolescent girls and young women but seems to be
occurring with increased frequency in the study population. This observation may indicate the biological behavior of
PT in a high risk population, though chances of referral bias are also present. In view of the rarity of the disease,
larger population studies are suggested to confirm our findings.
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component, arranged in clefts. The epithelial components
are surrounded by an over-growing hypercellular
mesenchymal component typically organized in leaf-like
structures. The PT is usually benign but recurrences are not
uncommon (Tavassol and Devilee, 2003). Metastases are
blood borne involving most frequently the lung and bones.
Treatment protocols are dependent upon tumor
categorization. This makes recognition of the entity
important both for clinicians and patients. The biological
behavior and prognosis of malignant PT is similar to
sarcomas of the breast.
The presentation of PT is of a relatively large, movable,
painless mass with a short history and rapid growth. The
lesion lacks complete encapsulation and extends into
surrounding tissue in multiple projections of different sizes.
Thus assessment of the margins is important to predict the
biological behavior of the lesion. Clinically PT is difficult
to evaluate. On mammogram, PT appears well defined with
a smooth and sometimes lobulated border.  Fine needle
aspiration (FNA) cytology is often diagnostic but may not
include sufficient tissue for microscopic evaluation of these
tumors; therefore, core biopsies are preferred. Complete
evaluation of PT may require several diagnostic tools
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including gross examination, radiology and cytological or
histological examination.
The objective of this study was to observe the frequency
of PT in adolescent girls and young women (less than and
equal to 25 years of age) and to define the clinico-
pathological features of PT in this unusual clinical setting.
Materials and Methods
This descriptive study was carried out at the Aga Khan
University Hospital (AKUH) pathology department. All
consecutive cases of PT diagnosed during the last sixteen
years in the section of histopathology from 1st January 1990
to 31st June 2005 were reviewed for the study. This included
cases primarily diagnosed at AKUH pathology department
and also second opinion slides of PT. Selection of cases was
restricted to patients up to 25 years of age, though the
frequency of all PT was also noted.
The incident cases of PT, ICD-O3 (WHO, 2000)
categories M-9020 were categorized by the age of the patient
and biological presentation of the tumor. All morphological
and biological types were included, BPT, BLPT and MPT.
Clinical and macroscopic information was taken from
archived pathology reports. The reported data were
rechecked. Variables recorded were the hospital patient-
number, date of incidence, name, age, sex, address,
topography, morphology, grading and staging.
Originally all specimens had been fixed in 10% buffered
formalin, grossed and representative sections taken
according to established protocols. The sections had been
routinely processed under standardized conditions for
paraffin embedding. The sections had been cut and stained
with hematoxylin and eosin (H&E) using a standard format
incorporating all the relevant parameters.
The reviewed cases were initially evaluated on archived
H&E stained sections and subsequently, where required
immunohistochemical analysis was performed by employing
envision technique. Immunohistochemical stains for desmin,
smooth muscle actin, S-100 etc. were examined to further
characterize the stromal elements. Only H&E slides were
available for a few of the second opinion cases, thus limiting
the use of immunochemistry in these cases.
The pathology department of AKU receives surgical
specimens from AKUH, Karachi and through 84 AKU
pathology laboratory collection points in Pakistan. It covers
a large geographical area, with collection points located in
all major cities like Karachi, Hyderabad, Multan, Lahore,
Quetta, Peshawar, Islamabad, Rawalpindi, Larkana and also
many rural locations.
The diagnosis of PT and its categorization into BPT,
BLPT and MPT was based on established criteria
recommend by WHO (WHO, 1981) to standardize with the
classification in other parts of the world. The criteria used
to classify histological types of PT included tumor margins
(pushing to infiltrating), stromal cellularity (low, moderate,
high) mitotic rate (per 10 HPF; <5, 5-9 and >10) and
pleomorphism (mild, moderate and severe). Stromal
overgrowth was defined as stromal proliferation to the point
where the epithelial elements are absent in at least 1 HPF
(40X) (Mollitt DL et al, 1987). The data were analyzed using
SPSS 13.0.
Quality control for diagnostic pathology is maintained
through internal and external quality checks. External quality
assurances for diagnostic pathology are maintained by the
College of American Pathologists (CAP) surveys. Internal
quality assurances are maintained by the use of histochemical
stains, immunohistochemical techniques. Biological markers
are used for malignancies, which necessitates cellular typing
and sub typing. The departmental consensus committee
confirms diagnosis.
Results
A total 42 cases of PT in up to 25 years of age were
selected for the study. This comprised 11% of the total PT
cases (total n=363). The number of BPT, BLPT and MPT
was identical i.e. 14 (33%) each. Thirty three cases were
primarily diagnosed at AKUH pathology department and 9
were second opinion slides of PT, originally diagnosed
elsewhere.
Data for patient age and tumor size are given in Table 1.
Clinically all cases presented with a single solid, mobile,
palpable mass. In the majority of cases in all three categories
of PT the surgical procedure was lumpectomy, which was
performed in 50% of the cases of BPT, 79% of BLPT and
64% of MPT. Mastectomy was performed in 7% BLPT and
28% MPT, but in none of the cases of BPT. A clinical history
of the surgical procedure performed was not available in
50% cases of BPT, 14% BLPT and 8% MPT. However the
specimen received suggested lumpectomy as the surgical
procedure performed. There was a marginal predisposition
to develop PT in the right breast (BPT 70%; BLPT 66.7%;
malignant 50.0%).
Microscopically tumor margins/borders were
Table 1. Phylloides Tumours in KarachiComparative
Studies
         Mean       Minimum  Maximum
Age Benign 19.1 (95% CI, 16.7-21.6) 13 25
Borderline 21.9 (95% CI, 20.7-21.9) 19 25
Malignant 19.7 (95% CI, 17.2-22.3) 13 25
Size Benign   6.5 (95% CI, 4.1-8.9) 1.5 14
Borderline   8.9 (95% CI, 4.5-13.3) 2.0 19
Malignant 11.0 (95% CI, 7.6-14.4) 5.0 19
Table 2. Comparison of Studies of Phylloides Tumours
Year Authors         Total        Pathological Diagnosis (%)
       BPT       BPLT MPT
1983 Briggs et al 44   84.1 2.3 13.6
1987 Mollitt et al   5   80.0 - 20.0
1992 Vesely et al   4 100.0 - -
1998 Prabha et al 45   75.6 17.8 6.6
2006 Current study 42   33.3 33.3 33.3
BPT, benign PT;  BPLT, borderline PT; MPT, malignant PT
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circumscribed in 46% of BPT cases . In BLPTs the borders
were circumscribed (16%), pushing (18%), or infiltrating
(6%). In the other 60% the border could not be assessed.
For MPTs the  border was infiltrating in 28% and unclear in
the remainder. Among MPTs a single case each of chondroid
differentiation, liposarcomatous change and osteosarcoma
was seen.
The microscopic morphology of PT in adolescent and
younger females was not distinguishable from PT that occurs
in old age, in our study. Among various histological features
stromal cellularity was mild in the majority of cases of BPT,
moderate in BLPT and marked in MPT. The mean number
of mitotic figures was 7/HPF (95% CI 3.0-11.8) minimum
4/HPF, maximum 17/HPF in BLPT and 13/HPF (95% CI
7.3-19) minimum 8/HPF, maximum 20/HPF in MPT. The
mitotic activity was infrequent in BPT.
Discussion
The results of the current study indicate that there is an
equal distribution of BPT, BLPT and MPT in the study
population. As this is an uncommon breast tumor and very
infrequent in the young age, no literature has yet been
published for Karachi, and/or for Pakistan. There are very
few international studies published on subject, thus
restricting comparison (see Table 2).
In the  series of cases up to 25 years of age published in
1998 by Prabha et al less stringent criteria were used to
classify histological subtypes of PT. According to their
criteria the mitotic rate for BPT, BPLT and MPT was 0-1, 2-
5 and >5 per high power field (HPF), respectively, whereas
we used the WHO classification which has a higher mitotic
count for sub-categorization of PT i.e. <5, 5-9 and >10 per
HPF for BPT, BPLT and MPT respectively. If we had used
Prabha’s criteria we would have had a much higher frequency
of BLPTs and MPTs in our series. Thus we suggest that
there is probably a more aggressive disease in our population.
The findings of Briggs et al (1983) also supported an
excess of lesions with poorer prognosis in our population.
We also compared our data with a study in India (Inder
et al, 2001) extending over a 20 year contemporary period,
in a similar geographical area. Only 1 case of BPT was
reported. Mollitt et al in 1987 reported a single case of MPT
out of 5 PTs in their series of adolescent females, with a
range of 13 to 18 years. The other 4 cases were BPTs. Vesely
et al in 1992 presented 4 cases of PT all benign in their
study of in-pubertal girls aged 11-15 years. Unfortunately,
there have not been enough statistical numbers of studies or
cases in studies to study this lesion more adequately. On the
basis of the limited published data available for comparison,
we suggest that we not only have a more aggressive disease,
but also at a younger age. This is an important point to
appreciate as WHO indicates that PT usually arises in the
4th or 5th decade and the MPT develops 4 to 5 years later
than BPT.
We reached similar conclusions when our study was
compared with other published studies. An article published
from Athens (Elshiekh et al, 2000) regarding breast tumors
during adolescence showed that in a 22 years period there
was only one case of PT. No explanation of the low frequency
was given. The probable explanation that the upper limit of
age in their study was 20 years, does not entirely explain
the low frequency of BLPT and MPT. Histologically PT
occurring in young women are indistinguishable from PT
in older women (Prabha et al 1998).
FA is widely accepted as the most common neoplasm in
adolescent girls (Prabha B et al 1998). Therefore FA comes
in close differential diagnosis of BPT. It is difficult clinically
to differentiate FA from BPT, except by histological
confirmation. Though the size of the lesion is important for
differentiation, it is not a very helpful parameter. The average
size of juvenile fibroadenoma (JFA) in literature is 3.8 cm
which is only slightly smaller than the mean size of BPT in
our study i.e. 6.5 cms.
Tumor borders are important for the assessment of the
malignant potential of PT. We could not assess the borders
in some of the lumpectomy cases as in these cases we had
received enucleated excision specimens and adjacent normal
breast tissue was not available for. In cases where the margins
could not be assessed the diagnosis was based on the other
3 recommended criteria.
A precise histopathological assessment of PT is essential,
as the management depends on histopathology and the
treatment of PT remains controversial. In the current study,
lumpectomy was performed in all the cases of BPT, 78% of
BLPT and 64% of MPT, this seems to be in line with
advocated management. Most studies advocate that benign
lesions can be managed with local excision (enucleation)
using a cosmetic incision. Borderline or malignant cases
should be treated with wide local excision (simple
mastectomy) or re-excision to negative margins. Failure of
complete excision results in local recurrence. Recurrence
of PT is usually treated with further surgery. Since lymph
node involvement is rare (10%) in MPT, axillary dissection
may or may not be done. Axillary dissection is recommended
only if nodes are palpable. When PT's metastasize, they
usually do so through the blood vessels, with no lymph node
involvement.  Most common sites for metastatic growth are
the lungs, bone, and abdominal viscera.
Benign tumors can be very aggressive in their growth
and recurrence rates. Consequently, it has been suggested
that all PT should be regarded as having a malignant
potential. Life-time close follow-up is therefore mandatory.
In our study we were unable to follow-up the patients,
therefore are unable to determine the rate of recurrence, if
any.
In conclusion, high grade PT (BLPT and MPT) is an
uncommon mammary tumor in adolescent girls and young
women but seems to be occurring with increased frequency
in the study population. This observation may indicate the
biological behavior of PT in a high risk population, though
chances of referral bias are also present. In view of the rarity
of the disease, larger population studies are suggested to
confirm our findings.
Amna Khurshid et al
Asian Pacific Journal of Cancer Prevention, Vol 7, 2006566
References
Azzopardi JG. (1979) Sarcomas of the breast.  In ‘Problems in
Breast Pathology’. Philadelphia: WB Sanders. 192-203.
Briggs RM, Walters M, Rosenthal D (1983). Cystosarcoma
phylloides in adolescent female patients.  Am J Surg, 146, 712-
4.
Chua CL, Thomas A, Ng BK. (1988) Cytosarcoma phylloides.
Asian variations. Aust NZ J Surg, 58, 301-5.
Elshiekh A, Keramopoulos A, Lazaris D, et al (2000). Breast
tumors during adolescence. Eur J Gynaecol Oncol, 21, 408-
10.
Inder M, Vaishnav K, Mathur DR. (2001) Benign breast lesions in
prepubertal. Female children – a study of 20 years. J Indian
Med Assoc, 99,  619-20.
Mollitt DL, Golladay ES, Gloster ES, Jimenez JF (1987).
Cystosarcoma phylloides in the adolescent female. J Pediatr
Surg, 22, 907-10.
Mullaer J (1838). Ueber den feieren Bau and die Formen der
krankhaften Art Geschwulster. Berlin: Reimer. 54.
Prabha B, Milicent L, Rosen P. (1998) Cytosarcoma phylloides in
adolescent girls and young women. Am J Surg Pathol, 22, 64
-9.
Tavassoli FA, Devilee P(Eds) (2003). World HealthOrganization
Classification of Tumors, Pathology and Genetics of Tumors
of the Breast and Female Genital organs. IARC Press: Lyon
Pg. 100
Vesely F, Baco E, Hudcova D (1992). Cystosarcoma phylloides
in adolescent women. Rozhl Chir, 71, 456-63 (in German).
Ward RM and Evan HL (1986). Cytosarcoma phylloides. A
clinicopathologic study of 26 cases. Cancer, 58, 2282-9.
World Health Organisation (2000). International Classification of
Diseases for Oncology, 3rd Edition. WHO, Geneva.
World Health Organization (1981) International Histological
Classification of Tumors: Histological Types of Breast Tumors.
Geneva.
